The insider selling of Agilysys shares, particularly by the Senior VP & CFO, may worry shareholders. Despite high insider ownership, the absence of insider buying recently and significant selling activity suggest caution.
Agilysys' high P/S ratio is justified by its strong revenue growth trajectory. Market participants exhibit faith in the company's sound revenue forecasts and appear ready to pay more for the stock, potentially supporting its price level.
Agilysys Q2 results point to strong operational efficiency despite reduced gross margin, driving a 21.7% rise in stock. Analysts noted its business structure supports a high growth strategy with stable cash and positive flow.
Analysts identify Agilysys as a profitable, growing entity worth monitoring, given its EPS growth and substantial insider investment. They speculate its growth trend could indicate a key turning point, indicating possible prospects for investors.
Despite revenue growth, Q2 Holdings, Matterport, and Agilysys offered lackluster Q2 performance and weaker guidance. Toast and Veeva Systems outperformed, with Toast showing notable sales guidance. Still, except for Veeva Systems, stock prices lowered for all due to a potential sector downturn amid a pivot from costly tech stocks to profit-led investments spurred by rising interest rates.
The frequent insider selling of Agilysys shares in the last year, notably the past three months, may cause investing consternation. The net selling volume could appear bearish, given that insider ownership isn't very high, urging cautious investing.
Upgrades •$Carvana(CVNA.US)$: Raymond James Upgrades to Market Perform from Underperform •$紐曼礦業(NEM.US)$: Canaccord Upgrades to Buy from Hold - PT $66 (from $60) •$印北瓦電(NI.US)$: Edward Jones Upgrades to Buy from Hold •$斯倫貝謝(SLB.US)$: Benchmark Upgrades to Buy from Hold - PT $55 Downgrades •$阿吉賽斯(AGYS.US)$: Craig-Hallum Downgrades to Hold from Buy •$克利夫蘭克里夫(CLF.US)$: GLJ Research Downgrades t...
阿吉賽斯股票討論區
In reaction to earnings/guidance:
• $梯瓦製藥(TEVA.US)$ +24%(also announces agreement for opioids settlement), $Enphase Energy(ENPH.US)$ +9.5%, $Spotify Technology(SPOT.US)$ +9.2%, $RPC Inc(RES.US)$ +8.5%, $奇波雷墨西哥燒烤(CMG.US)$ +8.2%, $Manhattan Associates(MANH.US)$ +8.1%, $希爾頓酒店(HLT.US)$ +6.7%, $ChampionX(CHX.US)$ +6.1%, $Mr. Cooper Group(COOP.US)$ +5.7%, $Constellium(CSTM.US)$ +5.5%, $波士頓科學(BSX.US)$ +5.4%,...
• $Carvana(CVNA.US)$ : Raymond James Upgrades to Market Perform from Underperform
• $紐曼礦業(NEM.US)$ : Canaccord Upgrades to Buy from Hold - PT $66 (from $60)
• $印北瓦電(NI.US)$ : Edward Jones Upgrades to Buy from Hold
• $斯倫貝謝(SLB.US)$ : Benchmark Upgrades to Buy from Hold - PT $55
Downgrades
• $阿吉賽斯(AGYS.US)$ : Craig-Hallum Downgrades to Hold from Buy
• $克利夫蘭克里夫(CLF.US)$ : GLJ Research Downgrades t...
暫無評論